Question follow-through · 82215
Rare Cancers: Medical Treatments
To ask the Secretary of State for Health and Social Care, what assessment his Department has made of the potential merits of minimally invasive therapies for the less survivable cancers.
About this written question
A written question asks a government minister for information in writing. Parliament publishes the question and any answer.
- Answering body
- Department of Health and Social Care
- Tabled
- 14 Oct 2025
- Target answer date
- 16 Oct 2025
- Answer
- 28 Oct 2025 · 14 calendar days after tabling
Elapsed calendar days describe the record timeline, not whether Parliament considers an answer on time.
More questions by this MP on Health and care
- Abiraterone · 17 Oct 2025
- Abiraterone · 17 Oct 2025
- Prostate Cancer: Abiraterone · 17 Oct 2025
- Abiraterone · 17 Oct 2025
- Abiraterone · 17 Oct 2025
Shared topic keywords suggest a connection; they do not establish a follow-up.
Votes on this topic
- Terminally Ill Adults (End of Life) Bill: Second Reading · 11 Sept 2026
- Health Bill: Report Stage: Amendment 1 · 8 Sept 2026
- Health Bill: Report Stage: New Clause 143 · 8 Sept 2026
These Commons divisions share a topic label. The question did not necessarily lead to a vote.
Recorded timeline
14 Oct 2025
Question tabled
To ask the Secretary of State for Health and Social Care, what assessment his Department has made of the potential merits of minimally invasive therapies for the less survivable cancers.
16 Oct 2025
Target answer date
Date supplied by the official written-questions record.
28 Oct 2025
Answer published
Ongoing research is exploring the potential of minimally invasive cancer therapies for less survivable cancers. This includes non-invasive liver cancer treatments that use ultrasound technology to destroy tumours without surgery, scalpels, or radiation, w...
Official data retrieved 28 Sept 2026.
Later records
Possible follow-up questions
Strong links require the same MP, department and exact heading. Other same-department questions are shown as unreviewed candidates, not as confirmed follow-ups. No debate link is asserted unless a stable source relationship exists.
Abiraterone
17 Oct 2025 · To ask the Secretary of State for Health and Social Care, what estimate his Department has made of the number of men in England with newly diagnosed high-risk, non-metastatic prostate cancer who would be eligible for abiraterone under the eligibility crit
Abiraterone
17 Oct 2025 · To ask the Secretary of State for Health and Social Care, if he will make an estimate of the potential impact of prescribing abiraterone in England using the eligibility criteria used in (a) Scotland and (b) Wales on the number of premature deaths from hi
Prostate Cancer: Abiraterone
17 Oct 2025 · To ask the Secretary of State for Health and Social Care, if he will make an estimate of the (a) cost per patient, (b) number of eligible patients, (c) net cost, (d) incremental quality-adjusted life years gained and (e) incremental cost-effectiveness rat
Abiraterone
17 Oct 2025 · To ask the Secretary of State for Health and Social Care, whether NHS England has approved any drugs with a higher incremental cost-effectiveness ratio than abiraterone for high-risk, non-metastatic prostate cancer in the last five years.
Abiraterone
17 Oct 2025 · To ask the Secretary of State for Health and Social Care, what information his Department holds on the estimate made by (a) NHS England, (b) NHS Wales and (c) NHS Scotland of the incremental cost-effectiveness ratio for abiraterone in high-risk, non-metas
Abiraterone
17 Oct 2025 · To ask the Secretary of State for Health and Social Care, for what reason NHS England has not approved abiraterone for use in high-risk, non-metastatic prostate cancer.
Abiraterone
17 Oct 2025 · To ask the Secretary of State for Health and Social Care, whether the NICE guidance on abiraterone produced in 2021 was based on abiraterone's cost in generic form.
Respiratory Diseases: Health Services
26 Nov 2025 · To ask the Secretary of State for Health and Social Care, whether his Department plans to publish a modern service framework for respiratory health.
Vaccination: Finance
1 Dec 2025 · To ask the Secretary of State for Health and Social Care, what proportion of NHS England’s total budget has been allocated to vaccination and immunisation programmes in each of the last five years.
Respiratory Syncytial Virus: Vaccination
1 Dec 2025 · To ask the Secretary of State for Health and Social Care, what assessment he made of the difference in uptake rates between maternal and infant RSV immunisations when developing the national immunisation programme.
Alcoholic Drinks: Labelling
1 Dec 2025 · To ask the Secretary of State for Health and Social Care, whether his Department has assessed the importance of including accessible behaviour-change and drinking moderation tools, including links to digital health support, as part of the new mandatory al
Alcoholic Drinks: Labelling
1 Dec 2025 · To ask the Secretary of State for Health and Social Care, whether his Department has assessed how alcohol labelling reforms could support local public-health and community-based initiatives aimed at reducing alcohol-related harm, particularly in areas wit